| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Sep 2, 2021 | Option exercise(M) | 13K | $3.07 | $40K | 32K |
| Sep 2, 2021 | Option exercise(M) | 18K | $3.07 | $57K | 18K |
| Aug 23, 2021 | Sell(S) | 34K | $13.11 | $442K | 0 |
| Aug 19, 2021 | Option exercise(M) | 27K | $3.07 | $84K | 34K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Sep 2, 2021 | Grant(A) | 8K | — | $0 | 34K |
| Sep 2, 2021 | Conversion(C) | 21K | $3.07 | $63K | 29K |
| Sep 2, 2021 | Grant(A) | 10K | — | $0 | 26K |
| Sep 2, 2021 | Conversion(C) | 29K | $3.07 | $89K | 72K |
| Aug 19, 2021 | Grant(A) | 16K | — | $0 | 16K |
| Aug 19, 2021 | Conversion(C) | 43K | $3.07 | $132K | 101K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000950142-21-003504) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for NRX Pharmaceuticals, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.